EMG
CYTK icon

Ellington Management Group’s Cytokinetics CYTK Stock Holding History

Ellington Management Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,700
Closed -$128K – 854
2017
Q4 		$128K Buy
+15,700
New +$178K 0.02% 539
2016
Q4 		– Sell
-10,000
Closed -$92K – 589
2016
Q3 		$92K Buy
+10,000
New +$104K 0.03% 616
2016
Q1 		– Sell
-13,600
Closed -$142K – 540
2015
Q4 		$142K Buy
+13,600
New +$133K 0.05% 511
2014
Q1 		– Sell
-36,300
Closed -$236K – 637
2013
Q4 		$236K Buy
+36,300
New +$238K 0.08% 393

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Ellington Management Group's CYTK Position: Q1 2018 in Review

Ellington Management Group sold out of Cytokinetics (CYTK) in Q1 2018, closing a stake of 15,700 shares — an estimated $128K sold.

Ellington Management Group first reported a position in CYTK in Q4 2013 and held it in 4 quarters. The position peaked at $236K in Q4 2013. 127 funds tracked by Wall St. Rank hold CYTK as of Q1 2018.

  • Ellington Management Group reported no remaining Cytokinetics position as of Q1 2018 after selling out during the quarter.
  • Ellington Management Group sold 15,700 Cytokinetics shares in Q1 2018, an estimated $128K.
  • Ellington Management Group first reported a position in Cytokinetics in Q4 2013 and held it in 4 quarters.
  • Ellington Management Group's Cytokinetics position peaked at $236K in Q4 2013.
  • 127 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2018.

Based on Ellington Management Group's 13F filing for Q1 2018, filed 15 May 2018.